Who founded Neuronostics?

Neuronostics was founded by John Terry.

Who are Neuronostics's investors?

Neuronostics's investors include New Wave Ventures, The FSE Group, Ascension Ventures, British Business Bank, Empirical Ventures, Innovate UK.

Neuronostics

10 known investors

Find your way into Neuronostics

332 people in our graph share verified history with the Neuronostics team — schools, employers, funds. One of them is your warm intro.

Joseph Jeongunlockedknows John Terry · together at Georgia Institute of Technology (overlapped)

×3knows the team · via University of Sheffield

×2knows the team · via Georgia Institute of Technology

knows the team · via University of Bristol

knows the team · via University of Reading

knows the team · via University of Plymouth

Neuronostics develops BioEP, software that applies digital analysis of background EEG to generate biomarkers supporting epilepsy diagnosis for clinicians and neurology services. The product aims to make epilepsy diagnostics more efficient and enable earlier, more accurate diagnoses.

AI & Machine Learning Digital Health Medical Devices

Founders & leadership

John Terry inCo-FounderJohn Terry is a Professor of Digital Health Innovation at the University of Plymouth with research expertise in neuroscience and epilepsy, and holds senior leadership experience from the University of Exeter and University of Birmingham. He is founder and Managing Director of Neuronostics Ltd, which develops digital clinical decision support systems for neurological conditions including epilepsy diagnostics.

Investors · 10

New Wave VenturesLondon

The FSE GroupFleet

Ascension Venturesreported · 2 sourcesSaint Louis · $10M – $20M

British Business BankreportedSheffield

Empirical Venturesreported · 2 sourcesLondon

Innovate UKreportedLondon

Also in the syndicate · 4

Angel Investors BristolBritish Business Bank (South West Investment Fund)New Wave Venture PartnersQantX

Funding

SEC filings, press & company announcements

Undisclosed amountGrowthJul 2026
Angel Investors Bristol, Ascension Ventures, British Business Bank (South West Investment Fund), Empirical Ventures, Innovate UK, New Wave Venture Partners, QantX, The FSE Group
Source ↗
Undisclosed amountseed roundApr 2024
Source ↗
Undisclosed amountpre-seed funding roundMar 2021
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Neuronostics raises £3M for epilepsy brain-monitoring platform. Cambridge South station opens, serving Biomedical Campus. Enhertu wins EU approval as tumour-agnostic HER2 therapy.cambridgebiocapital.substack.com · Jul 2026

UK tech funding roundup: This week's deals from Gaussion to Neuronostics - UKTNuktech.news · Jul 2026

Neuronostics raises £3m to advance biomarker platform for epilepsy - UKTNuktech.news · Jun 2026

Neuronostics raises £3M - The FSE Groupthefsegroup.com · Jun 2026

MedTech startup Neuronostics raises over £2M in oversubscribed seed round - University of Exeter Newsnews.exeter.ac.uk · Apr 2024

Neuronostics close oversubscribed pre-seed funding round - Neuronosticsneuronostics.com · Mar 2021

Frequently asked questions

What does Neuronostics do?: Neuronostics develops BioEP, software that applies digital analysis of background EEG to generate biomarkers supporting epilepsy diagnosis for clinicians and neurology services. The product aims to make epilepsy diagnostics more efficient and enable earlier, more accurate diagnoses.
Who founded Neuronostics?: Neuronostics was founded by John Terry.
Who are Neuronostics's investors?: Neuronostics's investors include New Wave Ventures, The FSE Group, Ascension Ventures, British Business Bank, Empirical Ventures, Innovate UK.